01 — Financials
Financial overview
Revenue
SEK 31,314,231
Period ending 2024-12-31
Operating profit
SEK 1,790,499
Profit before tax
SEK 1,793,471
Net profit
SEK 1,358,943
Total assets
SEK 8,461,470
Equity
SEK 3,946,147
Latest reporting period ending 2024-12-31
02 — Signals & news
Recent activity
No signals tracked yet
Funding rounds, hiring activity, and leadership changes will appear here when detected
Set up alerts for this company
Get notified about funding, hiring, and leadership changes
03 — Get in touch
Reach AOP ORPHAN PHARMACEUTICALS SWEDEN AB NUF
Key people
Christian Anders Feinberg
Daglig leder
Draft an intro emailpro
AI-generated contextual outreach
Prepare a meeting briefpro
One-page summary for your next call
Find decision-makerspro
Search by role and seniority
04 — Similar companies
Companies like AOP ORPHAN PHARMACEUTICALS SWEDEN AB NUF
Similar company matching coming soon
We're building AI-powered matching based on industry, size, location, and business model
Discover companies in our directory
Search >100,000 Nordic companies by name, industry, or location
Get the full picture on AOP ORPHAN PHARMACEUTICALS SWEDEN AB NUF
Financial history, alerts, outreach tools, and more. Free to use within limits.
Sign up free